These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14550871)

  • 1. Primary sclerosing cholangitis.
    Cullen S; Chapman R
    Autoimmun Rev; 2003 Oct; 2(6):305-12. PubMed ID: 14550871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of primary sclerosing cholangitis.
    Worthington J; Cullen S; Chapman R
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):93-103. PubMed ID: 15879616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiopathogenesis of primary sclerosing cholangitis.
    Chapman R; Cullen S
    World J Gastroenterol; 2008 Jun; 14(21):3350-9. PubMed ID: 18528932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of primary sclerosing cholangitis.
    Pollheimer MJ; Halilbasic E; Fickert P; Trauner M
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):727-39. PubMed ID: 22117638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiopathogenesis of primary sclerosing cholangitis.
    Cullen S; Chapman R
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):577-89. PubMed ID: 11492969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology and pathogenesis in primary sclerosing cholangitis.
    Boberg KM; Lundin KE; Schrumpf E
    Scand J Gastroenterol Suppl; 1994; 204():47-58. PubMed ID: 7824878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
    Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
    Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and senescence in fibrosing cholangiopathies.
    Nakanuma Y; Sasaki M; Harada K
    J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
    Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for primary sclerosing cholangitis.
    Vierling JM
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):591-610. PubMed ID: 11492970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells.
    Berglin L; Björkström NK; Bergquist A
    Scand J Gastroenterol; 2013 Jun; 48(6):719-28. PubMed ID: 23713804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
    Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K
    J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiopathogenesis of primary sclerosing cholangitis.
    O'Mahony CA; Vierling JM
    Semin Liver Dis; 2006 Feb; 26(1):3-21. PubMed ID: 16496229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
    Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
    Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.
    Karrar A; Broomé U; Södergren T; Jaksch M; Bergquist A; Björnstedt M; Sumitran-Holgersson S
    Gastroenterology; 2007 Apr; 132(4):1504-14. PubMed ID: 17408653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of sclerosing cholangitis without pancreatic involvement thought to be associated with autoimmunity.
    Sawai H; Matsubayashi H; Sasaki K; Tanaka M; Kakushima N; Takizawa K; Yamaguchi Y; Ono H
    Intern Med; 2011; 50(5):433-8. PubMed ID: 21372453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using GWAS to identify genetic predisposition in hepatic autoimmunity.
    Webb GJ; Hirschfield GM
    J Autoimmun; 2016 Jan; 66():25-39. PubMed ID: 26347073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphite oxidase (SO) - a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis.
    Preuß BE; Berg CP; Werner C; Plankenhorn S; Malek NP; Klein R
    BMC Gastroenterol; 2018 May; 18(1):58. PubMed ID: 29720090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.